Post-Therasense inequitable conduct: a pharmaceutical perspective
{{output}}
This article explores the policies behind and recent changes to the inequitable conduct defense in US patent law. Recognizing problems with the doctrine, the Federal Circuit clarified and heightened the underlying materiality and intent to deceive standards fo... ...